Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 13c

November 8, 2012 7:18 AM EST Send to a Friend
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 EPS of $0.19, $0.13 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $37.5 million versus the consensus estimate of $32 million.

For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment